A detailed history of Rhumbline Advisers transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 107,645 shares of ORGO stock, worth $415,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,645
Previous 113,012 4.75%
Holding current value
$415,509
Previous $316,000 2.85%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.42 - $3.24 $12,988 - $17,389
-5,367 Reduced 4.75%
107,645 $307,000
Q2 2024

Aug 01, 2024

BUY
$2.28 - $3.03 $7,834 - $10,411
3,436 Added 3.14%
113,012 $316,000
Q1 2024

May 09, 2024

BUY
$2.61 - $4.49 $8,224 - $14,147
3,151 Added 2.96%
109,576 $311,000
Q4 2023

Feb 08, 2024

SELL
$1.97 - $4.21 $2,029 - $4,336
-1,030 Reduced 0.96%
106,425 $435,000
Q3 2023

Nov 09, 2023

BUY
$2.34 - $4.43 $6,647 - $12,585
2,841 Added 2.72%
107,455 $341,000
Q2 2023

Aug 08, 2023

BUY
$1.9 - $4.3 $30,229 - $68,413
15,910 Added 17.94%
104,614 $347,000
Q1 2023

May 11, 2023

SELL
$1.89 - $2.93 $230,736 - $357,703
-122,083 Reduced 57.92%
88,704 $189,000
Q4 2022

Feb 14, 2023

BUY
$2.48 - $3.43 $39,925 - $55,219
16,099 Added 8.27%
210,787 $567,000
Q3 2022

Nov 10, 2022

BUY
$3.14 - $6.43 $52,764 - $108,049
16,804 Added 9.45%
194,688 $631,000
Q2 2022

Aug 11, 2022

BUY
$4.74 - $8.15 $94,008 - $161,638
19,833 Added 12.55%
177,884 $868,000
Q1 2022

May 12, 2022

BUY
$6.47 - $9.57 $253,675 - $375,220
39,208 Added 32.99%
158,051 $1.2 Million
Q4 2021

Feb 10, 2022

BUY
$9.02 - $13.5 $31,398 - $46,993
3,481 Added 3.02%
118,843 $1.1 Million
Q3 2021

Nov 12, 2021

SELL
$13.71 - $17.18 $31,190 - $39,084
-2,275 Reduced 1.93%
115,362 $1.64 Million
Q2 2021

Aug 05, 2021

BUY
$14.92 - $23.23 $1.49 Million - $2.32 Million
99,993 Added 566.73%
117,637 $1.96 Million
Q1 2021

May 06, 2021

BUY
$7.33 - $21.06 $26,065 - $74,889
3,556 Added 25.24%
17,644 $321,000
Q4 2020

Feb 10, 2021

BUY
$3.63 - $7.53 $6,388 - $13,252
1,760 Added 14.28%
14,088 $106,000
Q3 2020

Nov 12, 2020

SELL
$3.29 - $4.58 $11,498 - $16,007
-3,495 Reduced 22.09%
12,328 $47,000
Q2 2020

Aug 13, 2020

BUY
$2.86 - $4.61 $45,253 - $72,944
15,823 New
15,823 $61,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.